Antibody Response to Shiga Toxins in Argentinean Children with Enteropathic Hemolytic Uremic Syndrome at Acute and Long-Term Follow-Up Periods
2011

Antibody Response to Shiga Toxins in Argentinean Children with Hemolytic Uremic Syndrome

Sample size: 177 publication 10 minutes Evidence: moderate

Author Information

Author(s): Fernández-Brando Romina J., Bentancor Leticia V., Mejías María Pilar, Ramos María Victoria, Exeni Andrea, Exeni Claudia, Laso María del Carmen, Exeni Ramón, Isturiz Martín A., Palermo Marina S.

Primary Institution: División Inmunología, Instituto de Investigaciones Hematológicas, Academia Nacional de Medicina, Ciudad de Buenos Aires, Argentina

Hypothesis

The study aims to develop an ELISA to detect antibodies against Shiga toxin and evaluate its effectiveness in the Argentinean population.

Conclusion

The study found that both ELISA and Western blot methods can effectively detect antibodies to Shiga toxins in Argentinean children, differentiating HUS patients from healthy controls.

Supporting Evidence

  • 67% of normal healthy children showed reactivity for Stx2 antibodies.
  • 86% of HUS patients developed antibodies against Stx2.
  • HUS patients had a significantly higher frequency of antibodies against Stx2 A subunit compared to controls.
  • ELISA and Western blot methods were able to differentiate HUS patients from healthy controls with high specificity.
  • Antibody response was long-lasting in HUS patients, particularly against the A subunit.

Takeaway

The researchers wanted to see if they could find specific antibodies in kids with a serious illness caused by a bacteria, and they found a way to do it that works well.

Methodology

The study used ELISA and Western blot assays to detect antibodies against Shiga toxins in plasma samples from healthy children and HUS patients.

Potential Biases

Potential bias in patient selection and the reliance on specific diagnostic methods may affect the results.

Limitations

The study's findings may not be generalizable beyond the Argentinean population due to regional differences in STEC strains.

Participant Demographics

Participants included 72 normal healthy children and 105 HUS patients, with a median age of 32 months for HUS patients.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0019136

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication